ORIGINAL RESEARCH article
Sec. Alzheimer's Disease and Related Dementias
Volume 14 - 2022 | https://doi.org/10.3389/fnagi.2022.895535
Geometric deep learning reveals a structuro-temporal understanding of healthy and pathologic brain aging
- 1Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States
- 2Advanced Neuroimaging and Surgical Epilepsy (ANISE) Lab, Northwestern University, Chicago, IL, United States
- 3Mesulam Center for Cognitive Neurology and Alzheimer’s Disease, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States
- 4Department of Psychiatry and Behavioral Science, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States
- 5Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States
- 6Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA, United States
- 7Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States
Background: Brain age has historically been investigated primarily at the whole brain level. The ability to deconstruct the brain into its composite parts and explore brain age at the sub-structure level offers unique advantages. These include the exploration of dynamic and interconnected relationships between different brain structures in healthy and pathologic aging. To achieve this, individual brain structures can be rendered as surface representations on which morphologic analysis is carried out. Combining the advantages of deep learning with the strengths of surface analysis, we investigate the aging process at the individual structure level with the hypothesis being that pathologic aging does not uniformly affect the aging process of individual structures.
Methods: MRI data, age at scan time and diagnosis of dementia were collected from seven publicly available data repositories. The data from 17,440 unique subjects were collected, representing a total of 26,276 T1-weighted MRI accounting for longitudinal acquisitions. Surfaces were extracted for the cortex and seven subcortical structures. Deep learning networks were trained to estimate a subject’s age either using several structures together or a single structure. We conducted a cross-sectional analysis to assess the difference between the predicted and actual ages for all structures between healthy subjects, individuals with mild cognitive impairment (MCI) or Alzheimer’s disease dementia (ADD). We then performed a longitudinal analysis to assess the difference in the aging pace for each structure between stable healthy controls and healthy controls converting to either MCI or ADD.
Findings: Using an independent cohort of healthy subjects, age was well estimated for all structures. Cross-sectional analysis identified significantly larger predicted age for all structures in patients with either MCI and ADD compared to healthy subjects. Longitudinal analysis revealed varying degrees of involvement of individual subcortical structures for both age difference across groups and aging pace across time. These findings were most notable in the whole brain, cortex, hippocampus and amygdala.
Conclusion: Although similar patterns of abnormal aging were found related to MCI and ADD, the involvement of individual subcortical structures varied greatly and was consistently more pronounced in ADD patients compared to MCI patients.
The concept of brain age has been evolving since its introduction in the late 1960s (Oeriu, 1969). Advances in computational techniques and resources over the past 10 years have facilitated a dynamic expansion not only of our understanding of what brain age represents but how it can contribute to our understanding of healthy and disordered human aging. In the last 40 years, numerous studies have examined the relationship between neuroimaging-defined brain features and age using mass-univariate tests across brain voxels or regions. Hippocampal atrophy in both normal and pathologic aging patterns has been described across numerous investigations (Seab et al., 1988; Fox et al., 1996; Laakso et al., 1996; Jack et al., 1998). The temporal evolution of this atrophy may track age-related memory loss and aid in the diagnosis of various dementias, including Alzheimer’s disease dementia. Additionally, regional volume loss of the thalamus and putamen have been described in individuals with impaired memory (de Jong et al., 2008) while volume loss of peri-ventricular structures including the caudate, amygdala and thalamus have also been described (Ferrarini et al., 2006). Within the cortex, the regions suffering from volume loss are varied and include much of the neocortical regions involved in learning, memory and attention with cortical regions included in the default mode network the most consistently described as suffering from progressive atrophy in aging individuals (Kalpouzos et al., 2012).
Contrasted against the studies above that use age as an independent variable, brain age algorithms are trained to predict chronologic age based on features from thousands of individuals’ brain recordings or images. Many machine learning methods have been employed to predict age including linear and kernel regressions and deep learning. Examples for each include elastic net regression, relevance vector regression, or convolutional neural networks (CNN). Most prior brain age algorithms have used features derived from structural T1-weighted MR images (Franke et al., 2010; Gaser et al., 2013; Valizadeh et al., 2017; Wang J. et al., 2019). Less commonly, studies have predicted brain age with diffusion-weighted MRI (Mwangi et al., 2013; Tonnesen et al., 2020; Beck et al., 2021), functional MRI (Liem et al., 2017), MR angiography (Nam et al., 2020), FDG PET (Goyal et al., 2019), EEG (Sun et al., 2019; Paixao et al., 2020), or MEG (Engemann et al., 2020; Xifra-Porxas et al., 2021).
Despite the vast array of approaches used to determine brain age, most prior investigations have yielded a single per-participant prediction of brain age at the whole brain level, using an aggregate of all brain features at once. Popular approaches have used all structural MRI gray matter segmented voxels (Franke et al., 2010; Beheshti et al., 2018), while other studies have used regional thickness, surface area, and volume measurements (Kaufmann et al., 2019). More recent work have proposed morphological analysis using isosurfaces of functional brain imaging and successfully characterized neuropathologic-related features (Castillo-Barnes et al., 2020).
The ability to offer brain structure-specific analysis has been limited by the methods employed in previous investigations, specifically the analysis of the brain as a single structure yielding whole brain level predictions. This whole brain approach to aging has limited our ability to not only investigate the unique contribution of each individual brain structure or region to the aging process but also the role time plays in each structure’s contribution to aging.
Considering the brain not as a single structure but as a composite unit of multiple, dynamically interacting structures can offer a higher degree of granularity of exploration and understanding. The ability to deconstruct the brain into its component parts requires a different approach to analysis. Doing so requires the ability to extract information about each structure in isolation. Rendering individual brain structures as surface representations of their outer contour offers that opportunity. The investigation of brain morphology is a long-standing field of neuroscience. Van Essen posited that the brain’s shape, its fundamental sulcal and gyral patterns, are directly related to brain function due to underlying neuronal connectivity mounting similarly functioning brain regions into gyri and separating disparately functioning brain regions by sulci (Van Essen, 1997). Brain surface morphology has since been implicated in a variety of traits including personality, cognition and functional status (Whittle et al., 2009; Jockwitz et al., 2017; Cachia et al., 2018). Combining the advantages of CNN architectures with the strengths of brain surface analysis to advance Defferard’s graph CNN (gCNN) method into the neuroimaging domain (Defferrard et al., 2016; Besson et al., 2021), we developed surface based deep learning (SBDL) to fill this gap. Only a single prior investigation has explored structure-specific investigation of brain age and does so at a largely proof-of-concept level (Wachinger et al., 2015). In this pioneering work, which relied on the extraction of the eigenvalues of the Laplace-Beltrami operator calculated on the cortical surfaces and a selection of subcortical surfaces, the authors demonstrated that age could be accurately predicted using shape descriptors of individual brain structures.
Here, expanding our novel gCNN approach, we investigated individual structure age using a cross-sectional study design to assess structure age difference between healthy controls, MCI and ADD patients, and using a longitudinal study design to monitor the aging process of each structure and assess their dynamic implication in pathologic aging.
Materials and methods
MRI data, age at scan time and diagnosis of dementia were collected from seven publicly available data repositories. Data used in the preparation of this article were obtained from seven publicly available repositories of neuroimaging data, including the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database1, the details of which can be found in Table 1.
Subjects were included in this study if: (1) a diagnosis on dementia status was available: healthy, mild cognitive impairment or dementia, (2) if the presence of other neuropathologies could be excluded, (3) if their age at scan time was over 40 years old. Supplementary Table 1 lists the exclusion conditions of patients form the United Kingdom Biobank (Cox et al., 2019). The data of a total of 17,440 unique subjects were collected, which represented a total of 26,276 T1-weighted MRI accounting for longitudinal acquisitions. Table 1 summarizes the number of unique subjects, scans, and their age for each dataset. A diagnosis was assigned for each MR acquisition and therefore there is as many diagnosis labels as scans. Subjects were healthy for 19,610 scans, were diagnosed as MCI for 4,505 scans and diagnosed with Alzheimer’s disease dementia (ADD) for 5,206 scans.
To ensure a good generalization of brain age predictions, all included subjects were split into three independent datasets. A training set, composed of 11,523 unique healthy subjects picked at random among the subjects who had only one acquisition, a validation set containing 2,881 unique healthy subjects who also had only one acquisition, and the testing set included all remaining subjects. The split was performed at the subject level to prevent data leakage contamination (Wen et al., 2020).
The training and validation sets were solely used for training our networks. Once networks reached an accuracy that was deemed satisfactory, brain age was estimated for each scan of the testing which appeared as new, never seen data to our networks.
The testing set was solely used to generate Structure Age statistics (see Table 2). This set included 3,036 unique subjects for a total of 11,872 scans. Structure Age was assigned to each scan independently.
Table 2. Composition of the testing set, which was independent of the training set and was used to generate all results.
The overall steps for the data preparation were detailed in our previous work (Wu et al., 2020; Besson et al., 2021). All T1-weighted MRI were processed with Freesurfer (v6.02) using Northwestern University’s High Performance Computing Cluster (QUEST3). Preprocessing steps included bias field correction, intensity normalization, spatial normalization, skull stripping and tissue segmentation (Dale et al., 1999). The inner cortical surface, matching the white matter/gray matter junction, and the outer cortical surface, matching the gray matter/cerebro-spinal fluid interface, were then extracted. The surfaces were corrected for possible topological defects, inflated and parameterized (Fischl et al., 1999). Seven subcortical structures per hemisphere were automatically segmented using Freesurfer (amygdala, nucleus accumbens, caudate, hippocampus, pallidum, putamen, thalamus) and then modeled into surface meshes using SPHARM-PDM4. These structures were selected based on their size and contrast profile on T1 weighted imaging. All surfaces (inner and outer cortical surfaces and subcortical surfaces) were inflated, parameterized and registered to a corresponding surface template using a rigid-body registration to preserve the anatomy of the cortex and subcortical structures (Besson et al., 2014). This method was selected due to its demonstrated efficacy for morphological analyses (Castillo-Barnes et al., 2022).
Surface templates were converted to graphs based on their triangulation scheme (see Supplementary Figure 1). Nodes of the graphs were surface vertices, and edges of the graphs were segments across vertices. Overall, the graphs including all structures had 47,616 nodes, 32,768 from the cortical surfaces and 14,848 from the subcortical surfaces (see Table 3 for the number of nodes for each structure). Input features of the network were defined as the Cartesian coordinates of surface vertices in subjects’ native space resampled into the surface templates, centered around the origin (0, 0, 0) and divided by 100. Consequently, cortical nodes were assigned 6 features (X, Y, Z of both the inner and outer cortical surface vertices) and subcortical nodes had 3 features (X, Y, Z of subcortical surface vertices).
Graph convolutional neural networks
Cortical and subcortical meshes were converted to graphs, which provide a convenient representation of their shape. This, however, comes at the expense of using special convolutional operators capable of handling data mapped on graphs instead of traditional regular grids as it is the case with 2D or 3D images. For this purpose, and similarly to our previous work (Wu et al., 2020; Besson et al., 2021), we used the graph convolutional layers introduced in Defferrard et al. (2016). In brief, this approach allows convolution filters to be learnt on unstructured data such as graphs using finite support recursive Chebychev filters applied to underlying Laplacian matrix. This approach presents the advantage to be computationally efficient and uses local information in the same way as traditional 2D or 3D CNNs.
Using these convolutional layers, the principal difference with traditional CNN architectures is the pooling operator since unstructured data such as graphs don’t possess a natural arrangement such as images. To overcome this issue, we used a multiscale binary partitioning of the cortical and subcortical meshes (Wu et al., 2020). This ensures that, for all scales S, graph nodes n2i–1 and n2i with 1≤i≤NS/2 and NS is the number of graph nodes at scale S, are neighbors and to be pooled together using a 1D pooling operator (more details in Supplementary Figure 2). The total number of graph nodes at scale 0, N0, is therefore a parameter of the network and was picked so that it can be successively divided by 2 and the average Euclidean distance across neighbor nodes was less than 3 mm for the cortical meshes and less than 2 mm for the subcortical meshes.
The architecture of our graph convolutional neural network was based on the Residual Network architecture (He et al., 2016). Such architectures generally provide good performances, avoid the problem of vanishing gradients, and allow the training of very deep networks. We recently demonstrated that shortcut connections, as in Residual Networks architectures, improved the performances of gCNNs for the shape analysis of the subcortical structures (Azcona et al., 2021). The overall network architecture is illustrated in Figure 1A whereas the details about residual blocks are shown in Figure 1B. Our network uses a standard residual architecture with skipped connections in the residual blocks. Similarly to the Inception architecture (Szegedy et al., 2015) a first convolutional layer with a large receptive field is immediately followed by a pooling layer to reduce the dimension of the input and accelerate the training process without loss of performance. This was followed by three residual blocks, then by batch normalization, convolutional and global average pooling layers (GAP). Two independent dense layers used the output of the GAP layer: a dense layer followed by a ReLU activation aimed assigning ages to bins, whereas a dense layer followed by a Softmax activation aimed at assigning probabilities to the bins. This is in line with the recently published state-of-the-art network to estimate brain age (Peng et al., 2021), except that in our case we also made the centers of the bins learnable. Finally, the results obtained after the ReLU and Softmax activations were multiplied together and linearly combined using a last dense layer to provide the brain age estimate. The networks were implemented using Keras and Tensorflow 2.1 backend and Python 3.6.
Figure 1. (A) Overall architecture of the network. (B) Detail of Residual Blocks. For each convolutional layer (red), the kernel size k is indicated.
Network parameters and training
Ten structure-specific networks were trained: one network using all the structures together as inputs (cortical and subcortical), one network using only the cortex, one network with all the subcortical structures together only, and one network for each of the seven subcortical structures. Motivated by previous work demonstrating the value of network ensemble in brain age prediction (Levakov et al., 2020; Peng et al., 2021), twenty versions of each of the ten structure-specific networks were obtained using different seeds, therefore the total number of networks trained was 200. All networks had the same training parameters: convolutional layers had 64 filters except the very last convolutional layer which had 128 filters. Both dense layers had 75 units. The loss function was the mean squared error (MSE), the mean absolute error (MAE) was also monitored during training and validation. The optimization was done with the RMSprop algorithm with an initial learning rate set to 0.001. The learning rate was divided by 10 whenever the MAE on the validation set was not improved after 15 epochs, and the training was stopped if no improvement was obtained after 30 epochs. Networks were regularized with their L2 norm (λL2 = 10−12) and a dropout of 0.75 was applied to the dense layer of the Softmax branch.
To improve the generalizability of our models, we added a data augmentation technique before inference by applying randomized rotations within ± 15 degrees during training, and ± 5 degrees during validation. Moreover, test time augmentation (TTA) was set to 3 on the validation set to improve the accuracy and robustness of the predictions (Wang G. et al., 2019). To account for prediction bias (Beheshti et al., 2019; de Lange et al., 2019; Smith et al., 2019; Peng et al., 2021), prediction biases were estimated using local weighted regressions (LOWESS) for each structure using data from the validation set. Then, LOWESS curves were parametrized using piecewise smoothing splines (smoothing parameter set to 0.1).
Structure age prediction of the testing set
Brain age was predicted independently for each scan of the testing set, which have never been seen previously by the networks. The accuracy and robustness of the predictions were improved using TTA = 20 with the same data augmentation parameters as for the validation set, so that 400 brain age estimates were generated for each scan and each of the ten input structure combinations. All age predictions were averaged, and final age estimate was obtained after applying the piece-wise linear regression. The accuracy of structure age predictions was obtained by calculating the mean absolute error, the median absolute error, and the Person’s coefficients of correlation (r) between the predicted and actual age of the first acquisitions of healthy subjects in the testing set.
Cross-sectional analysis of baseline scans
A linear fixed effect was implemented to determine the effect of cognitive status on structure age prediction. Structure-wise age prediction along with diagnosis of all baseline scans were included in this analysis to fit the following model:
Where PAS,i is the predicted age for the structure S, patient i; Agei is the real age at the baseline acquisition of patient i; Diagnosisi is the diagnosis (healthy, MCI or ADD) of patient i at baseline acquisition; βS,0, βS,1 and βS,3 are structure-specific fixed effects coefficients and εS,i the residuals. This model seeks to answer the following question: given two subjects with the same real age, how does the diagnosis affect predicted age? All p-values were corrected for multiple comparisons using false discovery rate (FDR) (Benjamini and Hochberg, 1995).
Longitudinal analysis of structure age
A linear mixed effect model was implemented to examine the effect of cognitive status change (healthy subject, MCI or ADD) on the pace of structure aging from a morphological appearance perspective. The linear model aimed at answering the question: is there a relationship between the pace of structure aging and change in cognitive status over time, i.e., do structures age slower/faster in healthy subjects converting to MCI or ADD, as defined by their morphological appearance over time? For this purpose, we only included subjects with repeated scans, whose diagnosis at baseline scan was healthy and the age at last scan was at least 70 years old. For these subjects, all other scans along with the diagnosis were collected and subjects were grouped into one of the three categories: (1) Non-converters: baseline and last diagnosis are healthy; (2) MCI converters: baseline diagnosis is healthy and the last diagnosis is MCI; (3) ADD converters: baseline diagnosis is healthy and the last diagnosis is ADD. Using these data, the following model was fit:
Where PAS,i,j is the predicted age for the structure S, patient i and acquisition j; Agei,0 is the real age at baseline scan for patient i; Convert_typei is the type of conversion (healthy to healthy, healthy to MCI or healthy to AD) of patient i; Delta_scani,j is the duration between baseline scan and the j-th acquisition of patient i; βS,0, βS,1 and βS,2 are structure-specific fixed effects coefficients, bS,0,i is a structure-specific random intercept, bS,1,i a structure-specific random slope and εS,i,j the residuals. Aging slopes for MCI and AD were defined for all structures as the ratios between the fixed-effect coefficients βS,2 associated with MCI or AD with that associated with HC. All p-values were corrected for multiple comparisons using false discovery rate (FDR) (Benjamini and Hochberg, 1995).
Accuracy of structure age predictions
The accuracy of age prediction for each structure using the baseline scans of healthy controls from the independent testing set as well as the bias correction effectiveness are summarized in Figures 2, 3. Age was well estimated for all structures, the mean absolute error ranging from 3.30 years when using the caudate only, to 3.61 years when using the amygdala only or the putamen only. For all structures, the coefficient of correlation between the actual and the predicted structure age was at least 0.89.
Figure 2. Residuals of age predictions for all structures (cortex + subcortical) before and after bias correction. Bias correction effectively suppressed the effect of real age on the predicted age.
Figure 3. Accuracy of structure age prediction using the baseline acquisition of healthy subjects (95 CI: 95% confidence interval).
Cross-sectional analysis of baseline scans
The effect of diagnosis at baseline on structure age prediction is shown in Figure 4. Using only the baseline scans and diagnosis of all subjects, the predicted age for all structures was found significantly larger in patients with MCI and ADD compared to healthy subjects. The amygdala was found to have the largest effect as MCI patients were estimated to be 3.48 years older, and ADD patients 7.97 years older than healthy controls. On the other hand, the pallidum had the smallest effect as pallidum age was estimated to be 1.74 years older in MCI patients and 3.78 years older in ADD patients compared to healthy controls.
Figure 4. Effect of baseline diagnosis on structure age prediction (point estimate and 95% confidence intervals). The predicted age was significantly larger (p < 0.0001 FDR corrected) for all structures compared to healthy controls (group of reference, no effect) as well as between MCI and ADD groups.
Longitudinal analysis of structure age
The results of the mixed effect linear model for the longitudinal analysis of structure age predictions are presented in Table 4. Compared to healthy controls, MCI converters have significantly increased estimated age for the composite subcortical structures, as well as individual amygdala, caudate, hippocampus, pallidum and putamen. ADD converters have significantly increased estimated age for the whole brain (cortical + subcortical), composite subcortical structures, as well as individual accumbens, amygdala, hippocampus, pallidum and putamen. Overall, the aging pattern in ADD converters is similar but consistently more marked than the aging pattern of MCI converters compared to healthy controls, except for the caudate, found to be significantly increased in MCI converters only.
The aging pace, determined by the fixed effect term between the type of conversion and the time across scans (delta scan), was found largely and widespread increased in ADD converters compared to healthy controls with significantly faster aging affecting the whole brain, cortex, accumbens, amygdala, hippocampus and pallidum. A similar pattern of widespread increased aging pace was identified in MCI converters, although to a lesser degree and included only significant whole brain findings.
Successful prediction of brain age using structure-wise analysis
Using baseline MRI scans from healthy controls, accurate brain age was predicted using a combination of all brain structures combined as well as each individual brain structure in isolation. The accuracy of our results are equivalent or superior to those of others when taking the whole brain as a predictive model (Cole et al., 2017; Liem et al., 2017; Beheshti et al., 2022). The strong performance of each subcortical structure in isolation is notable. While this is a novel finding, it is not altogether unexpected due to the adjacency of the subcortical structures to the ventricles. Given the previously well-described relationship between the ventricles and brain age, this finding is congruent with previous reports (Scahill et al., 2003; Preul et al., 2006). Ours is the first work to investigate structure-wise prediction of brain age using a gCNN approach. While findings were relatively consistent across individual structures and when taking all structures together, variability across structures was identified. These findings suggest a unique but tandem contribution to brain aging exerted by each individual brain structure. Our findings utilizing a gCNN approach, corroborate those of others using non-graph based methods which have demonstrated enhanced brain age prediction when accounting for a combination of both local and regional metrics in the prediction algorithm (Beheshti et al., 2022).
Differences identified between healthy and pathologic aging populations
When comparing findings on baseline MRI between healthy and pathologic aging populations, including those with MCI and ADD, structure-wise analysis continues to reveal novel insights into these different populations. All brain structures analyzed together and individually revealed a consistent relationship between healthy, MCI and ADD populations including a modest increased deviation of predicted brain age in MCI and a more marked increased deviation of predicted brain age in ADD, both of which were significant compared to healthy controls and between pathologic entities.
The most notable increased deviations from chronologic age were found in the amygdala with an overestimation of brain age by nearly 3.5 and 8 years in MCI and ADD populations respectively, when predicting brain age from the surface of the amygdala alone. This was followed by an overestimation of brain age by analysis of the cortical ribbon alone by 3.4 and 6.7 years for MCI and ADD populations respectively, while the analysis of the hippocampus alone yielded an overestimation of brain age by 3.3 and 6.8 years for MCI and ADD populations, respectively.
The significant overestimation of structure-wise brain age in pathologic aging populations suggests a prominent role may be played by each of these individual brain structures in driving altered aging patterns. The findings involving the cortex and hippocampus are unsurprising in our current understanding of aging, however, the substantial role of the amygdala and putamen in pathologic aging has been less extensively investigated and discussed.
Our findings advance the work of Cuenod, Maunoury and others following their descriptions of amygdala atrophy serving as a marker of early ADD (Cuenod et al., 1993; Maunoury et al., 1996). More recently, disordered olfaction and specifically impairment of the olfactory amygdala in ADD has been discussed and postulated to be an early driver of ADD symptom onset (Ubeda-Banon et al., 2020).
Differential structuro-temporal evolution between groups
When comparing findings over time for individuals who remain healthy against those who convert from healthy to either MCI or ADD, gCNN analysis reveals insights into the temporal evolution of brain aging both at the whole brain and single-structure level. Specifically, individuals who convert to either MCI or ADD demonstrate an overestimated structure age (conversion fixed effect) compared to non-converters who remain healthy, but this overestimation is more modest than when statically comparing groups at a single point in time.
While the net brain age overestimations are relatively modest on these longitudinal comparisons, structure-wise gCNN analysis also provides novel temporal information regarding the pace of brain aging between groups over time. Overall, brain structures demonstrate a significantly faster pace (conversion delta scan interaction fixed effect) of brain aging within individuals converting to either MCI or ADD compared to non-converting healthy individuals with the exception of the caudate, putamen and thalamus which remain relatively aligned with healthy agers regardless of conversion status. Of the brain structures demonstrating a faster pace of brain aging in pathologic aging populations, the relative increase in aging pace was more pronounced in those converting to ADD compared to those converting to MCI. Ours is the first to represent these dynamic relationships between MCI and ADD converters at the whole brain and single structure levels.
An additional novel finding from this analysis yields overarching consistency across static and dynamic analyses. Specifically, the roles played by the cortex, hippocampus and amygdala within the pathologic aging processes characterized as MCI and ADD. Interestingly, the amygdala reveals a more pronounced static difference in brain age overestimation whereas the cortex-only model and amygdala-only model each demonstrate the most elevated pace of aging in ADD converters, specifically 38.08 and 35.84% faster rates of brain aging respectively, compared to healthy non-converters. This supports long standing work implicating the amygdala in the neurobiology of dementia given its role in both the cholinergic and serotonergic systems, long-thought to underpin the development of ADD and other dementia types (Rodriguez et al., 2012; Mesulam, 2013). This finding is also in keeping with prior work demonstrating accelerated atrophy of the amygdala in healthy adults at increased genetic risk of developing ADD (An et al., 2021) as well as in individuals with MCI and ADD (Feng et al., 2021). Taken together, these findings add to the growing body of literature that identifies a prominent role played by the amygdala in the pathophysiology of deteriorating cognitive function. Of note, the hippocampus demonstrates a relatively modest increased pace of aging in pathologic agers compared to healthy agers at 7.74% increase in MCI converters and 18.59% increase in ADD converters.
The results of this work must be interpreted within the constraints of large, publicly available database-based analyses investigating aging and cognition including the subjective criteria used to define MCI and ADD classification across multiple participating sites as well as multiple scanner and acquisition protocols used in MR data collection. Despite these limitations, we believe our findings advance our understanding of brain aging by providing a novel structuro-temporal understanding of aging in healthy and pathologic aging populations.
Data availability statement
All data used in this analysis are available as identified in Table 1.
PB and SB contributed to conception and design of the study and wrote the first draft of the manuscript. AM and ER provided subject matter input and guidance and provided critical review of the manuscript throughout its preparation. PB organized the database, performed all computational analysis, and created all figures and tables. PB and NG performed statistical analysis. HZ provided statistical input and guidance. All authors contributed to manuscript revision, read, and approved the submitted version.
This project was supported by P30AG013854, P30AG072977, and T32AG020506 from the National Institute on Aging. This research was supported in part through the computational resources and staff contributions provided for the Quest high performance computing facility at Northwestern University which is jointly supported by the Office of the Provost, the Office for Research, and Northwestern University Information Technology.
Data were provided in part by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University. Data collection and sharing for this project was funded by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number: W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie; Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd., and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research and Development, LLC.; Johnson & Johnson Pharmaceutical Research and Development LLC.; Lumosity; Lundbeck; Merck and Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer’s Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. Data were provided in part by OASIS: OASIS: Cross-Sectional: Principal Investigators: D. Marcus, R, Buckner, J, Csernansky J. Morris; P50 AG05681, P01 AG03991, P01 AG026276, R01 AG021910, P20 MH071616, U24 RR021382, OASIS: Longitudinal: Principal Investigators: D. Marcus, R, Buckner, J. Csernansky, J. Morris; P50 AG05681, P01 AG03991, P01 AG026276, R01 AG021910, P20 MH071616, U24 RR021382, OASIS-3: Principal Investigators: T. Benzinger, D. Marcus, J. Morris; NIH P50 AG00561, P30 NS09857781, P01 AG026276, P01 AG003991, R01 AG043434, UL1 TR000448, R01 EB009352. AV-45 doses were provided by Avid Radiopharmaceuticals, a wholly owned subsidiary of Eli Lilly. References for other databases: (Shafto et al., 2014; Zuo et al., 2014; Taylor et al., 2016; LaMontagne et al., 2019). Data used in the preparation of this work were obtained from the CamCAN repository (available at http://www.mrc-cbu.cam.ac.uk/datasets/camcan/), (Shafto et al., 2014; Taylor et al., 2016).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnagi.2022.895535/full#supplementary-material
- ^ https://adni.loni.usc.edu
- ^ https://surfer.nmr.mgh.harvard.edu
- ^ https://www.it.northwestern.edu/research/user-services/quest/
- ^ https://www.nitrc.org/projects/spharm-pdm/
An, N., Fu, Y., Shi, J., Guo, H. N., Yang, Z. W., Li, Y. C., et al. (2021). Synergistic effects of APOE and CLU may increase the risk of Alzheimer’s Disease: Acceleration of atrophy in the volumes and shapes of the hippocampus and amygdala. J. Alzheimers Dis. 80, 1311–1327. doi: 10.3233/JAD-201162
Azcona, E. A., Besson, P., Wu, Y., Kurani, A. S., Bandt, S. K., Parrish, T. B., et al. (2021). Analyzing brain morphology in Alzheimer’s Disease using discriminative and generative spiral networks. BioRxiv [Preprint]. 2021.2004.2015.440008. doi: 10.1101/2021.04.15.440008
Beck, D., de Lange, A. G., Maximov, I. I., Richard, G., Andreassen, O. A., Nordvik, J. E., et al. (2021). White matter microstructure across the adult lifespan: A mixed longitudinal and cross-sectional study using advanced diffusion models and brain-age prediction. Neuroimage 224:117441. doi: 10.1016/j.neuroimage.2020.117441
Beheshti, I., Maikusa, N., and Matsuda, H. (2018). The association between “Brain-Age Score” (BAS) and traditional neuropsychological screening tools in Alzheimer’s disease. Brain Behav. 8:e01020. doi: 10.1002/brb3.1020
Beheshti, I., Maikusa, N., and Matsuda, H. (2022). The accuracy of T1-weighted voxel-wise and region-wise metrics for brain age estimation. Comput. Methods Prog. Biomed. 214:106585. doi: 10.1016/j.cmpb.2021.106585
Benjamini, Y., and Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. Royal Statist. Soc. Series B 57, 289–300. doi: 10.1111/j.2517-6161.1995.tb02031.x
Besson, P., Lopes, R., Leclerc, X., Derambure, P., and Tyvaert, L. (2014). Intra-subject reliability of the high-resolution whole-brain structural connectome. NeuroImage 102, 283–293. doi: 10.1016/j.neuroimage.2014.07.064
Besson, P., Parrish, T., Katsaggelos, A. K., and Bandt, S. K. (2021). Geometric deep learning on brain shape predicts sex and age. Comp. Med. Imaging Graph. 91:101939. doi: 10.1016/j.compmedimag.2021.10 1939
Cachia, A., Roell, M., Mangin, J. F., Sun, Z. Y., Jobert, A., Braga, L., et al. (2018). How interindividual differences in brain anatomy shape reading accuracy. Brain Struct. Funct. 223, 701–712. doi: 10.1007/s00429-017-1516-x
Castillo-Barnes, D., Jimenez-Mesa, C., Martinez-Murcia, F. J., Salas-Gonzalez, D., Ramirez, J., and Gorriz, J. M. (2022). Quantifying differences between affine and nonlinear spatial normalization of FP-CIT spect images. Int. J. Neural. Syst. 32:2250019. doi: 10.1142/S0129065722500198
Castillo-Barnes, D., Martinez-Murcia, F. J., Ortiz, A., Salas-Gonzalez, D., RamIrez, J., and Gorriz, J. M. (2020). Morphological characterization of functional brain imaging by isosurface analysis in Parkinson’s Disease. Int. J. Neural. Syst. 30:2050044. doi: 10.1142/S0129065720500446
Cole, J. H., Poudel, R. P. K., Tsagkrasoulis, D., Caan, M. W. A., Steves, C., Spector, T. D., et al. (2017). Predicting brain age with deep learning from raw imaging data results in a reliable and heritable biomarker. Neuroimage 163, 115–124. doi: 10.1016/j.neuroimage.2017.07.059
Cox, S. R., Ritchie, S. J., Fawns-Ritchie, C., Tucker-Drob, E. M., and Deary, I. J. (2019). Structural brain imaging correlates of general intelligence in UK Biobank. Intelligence 76:101376. doi: 10.1016/j.intell.2019.101376
Cuenod, C. A., Denys, A., Michot, J. L., Jehenson, P., Forette, F., Kaplan, D., et al. (1993). Amygdala atrophy in Alzheimer’s disease. An in vivo magnetic resonance imaging study. Arch. Neurol. 50, 941–945. doi: 10.1001/archneur.1993.00540090046009
de Jong, L. W., van der Hiele, K. I, Veer, M., Houwing, J. J., Westendorp, R. G., Bollen, E. L., et al. (2008). Strongly reduced volumes of putamen and thalamus in Alzheimer’s disease: An MRI study. Brain 131, 3277–3285. doi: 10.1093/brain/awn278
de Lange, A. G., Kaufmann, T., van der Meer, D., Maglanoc, L. A., Alnaes, D., Moberget, T., et al. (2019). Population-based neuroimaging reveals traces of childbirth in the maternal brain. Proc. Natl. Acad. Sci. U. S. A. 116, 22341–22346. doi: 10.1073/pnas.1910666116
Defferrard, M., Bresson, X., and Vandergheynst, P. (2016). “Convolutional neural networks on graphs with fast localized spectral filtering,” in Proceedings of the Advance Neural Information Processing System, 3844–3852. Available online at: https://dl.acm.org/doi/10.5555/3157382.3157527
Engemann, D. A., Kozynets, O., Sabbagh, D., Lemaitre, G., Varoquaux, G., Liem, F., et al. (2020). Combining magnetoencephalography with magnetic resonance imaging enhances learning of surrogate-biomarkers. Elife 9:e54055. doi: 10.7554/eLife.54055
Feng, Q., Niu, J., Wang, L., Pang, P., Wang, M., Liao, Z., et al. (2021). Comprehensive classification models based on amygdala radiomic features for Alzheimer’s disease and mild cognitive impairment. Brain Imaging Behav. 15, 2377–2386. doi: 10.1007/s11682-020-00434-z
Ferrarini, L., Palm, W. M., Olofsen, H., van Buchem, M. A., Reiber, J. H., and dmiraal-Behloul, F. A. (2006). Shape differences of the brain ventricles in Alzheimer’s disease. Neuroimage 32, 1060–1069. doi: 10.1016/j.neuroimage.2006.05.048
Fischl, B., Sereno, M. I., and Dale, A. M. (1999). Cortical Surface-Based Analysis: II: Inflation, flattening, and a surface-based coordinate system. NeuroImage 9, 195–207. doi: 10.1006/nimg.1998.0396
Fox, N. C., Warrington, E. K., Freeborough, P. A., Hartikainen, P., Kennedy, A. M., Stevens, J. M., et al. (1996). Presymptomatic hippocampal atrophy in Alzheimer’s disease. A longitudinal MRI study. Brain 119, 2001–2007. doi: 10.1093/brain/119.6.2001
Franke, K., Ziegler, G., Kloppel, S., Gaser, C., and Alzheimer’s Disease Neuroimaging, I. (2010). Estimating the age of healthy subjects from T1-weighted MRI scans using kernel methods: Exploring the influence of various parameters. Neuroimage 50, 883–892. doi: 10.1016/j.neuroimage.2010.01.005
Gaser, C., Franke, K., Kloppel, S., Koutsouleris, N., Sauer, H., and Alzheimer’s Disease Neuroimaging, I. (2013). BrainAGE in mild cognitive impaired patients: Predicting the conversion to Alzheimer’s Disease. PLoS One 8:e67346. doi: 10.1371/journal.pone.0067346
Goyal, M. S., Blazey, T. M., Su, Y., Couture, L. E., Durbin, T. J., Bateman, R. J., et al. (2019). Persistent metabolic youth in the aging female brain. Proc. Natl. Acad. Sci. U. S. A. 116, 3251–3255. doi: 10.1073/pnas.1815917116
He, K. M., Zhang, X. Y., Ren, S. Q., and Sun, J. (2016). “Deep Residual Learning for Image Recognition,” in 2016 IEEE Conference on Computer Vision and Pattern Recognition (Cvpr), (Las Vegas, NV: IEEE), 770–778. doi: 10.1109/CVPR.2016.90
Jack, C. R. Jr., Petersen, R. C., Xu, Y., O’Brien, P. C., Smith, G. E., Ivnik, R. J., et al. (1998). Rate of medial temporal lobe atrophy in typical aging and Alzheimer’s disease. Neurology 51, 993–999. doi: 10.1212/wnl.51.4.993
Jockwitz, C., Caspers, S., Lux, S., Jütten, K., Schleicher, A., Eickhoff, S. B., et al. (2017). Age- and function-related regional changes in cortical folding of the default mode network in older adults. Brain Struct. Funct. 222, 83–99. doi: 10.1007/s00429-016-1202-4
Kalpouzos, G., Persson, J., and Nyberg, L. (2012). Local brain atrophy accounts for functional activity differences in normal aging. Neurobiol. Aging 33, 623.e1–623.e13. doi: 10.1016/j.neurobiolaging.2011.02.021
Kaufmann, T., van der Meer, D., Doan, N. T., Schwarz, E., Lund, M. J., Agartz, I., et al. (2019). Common brain disorders are associated with heritable patterns of apparent aging of the brain. Nat. Neurosci. 22, 1617–1623. doi: 10.1038/s41593-019-0471-7
Laakso, M. P., Partanen, K., Riekkinen, P., Lehtovirta, M., Helkala, E. L., Hallikainen, M., et al. (1996). Hippocampal volumes in Alzheimer’s disease, Parkinson’s disease with and without dementia, and in vascular dementia: An MRI study. Neurology 46, 678–681. doi: 10.1212/WNL.46.3.678
LaMontagne, P. J., Benzinger, T. L. S., Morris, J. C., Keefe, S., Hornbeck, R., Xiong, C., et al. (2019). OASIS-3: Longitudinal neuroimaging, clinical, and cognitive dataset for normal aging and Alzheimer Disease. MedRxiv [Preprint]. 2019.2012.2013.19014902. doi: 10.1101/2019.12.13.19014902
Levakov, G., Rosenthal, G., Shelef, I., Raviv, T. R., and Avidan, G. (2020). From a deep learning model back to the brain-Identifying regional predictors and their relation to aging. Hum. Brain Mapp. 41, 3235–3252. doi: 10.1002/hbm.25011
Liem, F., Varoquaux, G., Kynast, J., Beyer, F., Kharabian Masouleh, S., Huntenburg, J. M., et al. (2017). Predicting brain-age from multimodal imaging data captures cognitive impairment. Neuroimage 148, 179–188. doi: 10.1016/j.neuroimage.2016.11.005
Maunoury, C., Michot, J. L., Caillet, H., Parlato, V., Leroy-Willig, A., Jehenson, P., et al. (1996). Specificity of temporal amygdala atrophy in Alzheimer’s disease: Quantitative assessment with magnetic resonance imaging. Dementia 7, 10–14. doi: 10.1159/000106846
Mwangi, B., Hasan, K. M., and Soares, J. C. (2013). Prediction of individual subject’s age across the human lifespan using diffusion tensor imaging: A machine learning approach. Neuroimage 75, 58–67. doi: 10.1016/j.neuroimage.2013.02.055
Nam, Y., Jang, J., Lee, H. Y., Choi, Y., Shin, N. Y., Ryu, K. H., et al. (2020). Estimating age-related changes in in vivo cerebral magnetic resonance angiography using convolutional neural network. Neurobiol. Aging 87, 125–131. doi: 10.1016/j.neurobiolaging.2019.12.008
Paixao, L., Sikka, P., Sun, H., Jain, A., Hogan, J., Thomas, R., et al. (2020). Excess brain age in the sleep electroencephalogram predicts reduced life expectancy. Neurobiol. Aging 88, 150–155. doi: 10.1016/j.neurobiolaging.2019.12.015
Peng, H., Gong, W., Beckmann, C. F., Vedaldi, A., and Smith, S. M. (2021). Accurate brain age prediction with lightweight deep neural networks. Med. Image Anal. 68:101871. doi: 10.1016/j.media.2020.101871
Preul, C., Hund-Georgiadis, M., Forstmann, B. U., and Lohmann, G. (2006). Characterization of cortical thickness and ventricular width in normal aging: A morphometric study at 3 Tesla. J. Magn. Reson. Imaging 24, 513–519. doi: 10.1002/jmri.20665
Scahill, R. I., Frost, C., Jenkins, R., Whitwell, J. L., Rossor, M. N., and Fox, N. C. (2003). A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch. Neurol. 60, 989–994. doi: 10.1001/archneur.60.7.989
Seab, J. P., Jagust, W. J., Wong, S. T., Roos, M. S., Reed, B. R., and Budinger, T. F. (1988). Quantitative NMR measurements of hippocampal atrophy in Alzheimer’s disease. Magn. Reson. Med. 8, 200–208.
Shafto, M. A., Tyler, L. K., Dixon, M., Taylor, J. R., Rowe, J. B., Cusack, R., et al. (2014). The Cambridge Centre for Ageing and Neuroscience (Cam-CAN) study protocol: A cross-sectional, lifespan, multidisciplinary examination of healthy cognitive ageing. BMC Neurol. 14:204. doi: 10.1186/s12883-014-0204-1
Sun, H., Paixao, L., Oliva, J. T., Goparaju, B., Carvalho, D. Z., van Leeuwen, K. G., et al. (2019). Brain age from the electroencephalogram of sleep. Neurobiol. Aging 74, 112–120. doi: 10.1016/j.neurobiolaging.2018.10.016
Szegedy, C., Liu, W., Jia, Y., Sermanet, P., Reed, S., Anguelov, D., et al. (2015). “Going deeper with convolutions,” in Proceedings of the IEEE conference on computer vision and pattern recognition, (Boston, MA: IEEE). doi: 10.1109/CVPR.2015.7298594
Taylor, J. R., Williams, N., Cusack, R., Auer, T., Shafto, M. A., Dixon, M., et al. (2016). The cambridge centre for ageing and neuroscience (CamCAN) data repository: Structural and functional MRI, MEG, and cognitive data from a cross-sectional adult lifespan sample. NeuroImage 144(Pt B), 262–269 doi: 10.1016/j.neuroimage.2015.09.018
Tonnesen, S., Kaufmann, T., de Lange, A. G., Richard, G., Doan, N. T., Alnaes, D., et al. (2020). Brain age prediction reveals aberrant brain white matter in schizophrenia and bipolar disorder: A multisample diffusion tensor imaging study. Biol. Psychiat. Cogn. Neurosci. Neuroimaging 5, 1095–1103. doi: 10.1016/j.bpsc.2020.06.014
Ubeda-Banon, D. I, Saiz-Sanchez, A., Flores-Cuadrado, E., Rioja-Corroto, M., Villar-Conde, S., et al. (2020). The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases. Transl. Neurodegener. 9:22. doi: 10.1186/s40035-020-00200-7
Wachinger, C., Golland, P., Kremen, W., Fischl, B., and Reuter, M., and Alzheimer’s Disease Neuroimaging Initiative (2015). BrainPrint: A discriminative characterization of brain morphology. Neuroimage 109, 232–248. doi: 10.1016/j.neuroimage.2015.01.032
Wang, G., Li, W., Aertsen, M., Deprest, J., Ourselin, S., and Vercauteren, T. (2019). Aleatoric uncertainty estimation with test-time augmentation for medical image segmentation with convolutional neural networks. Neurocomputing 335, 34–45.
Wang, J., Knol, M. J., Tiulpin, A., Dubost, F., de Bruijne, M., Vernooij, M. W., et al. (2019). Gray Matter Age Prediction as a Biomarker for Risk of Dementia. Proc. Natl. Acad. Sci. U. S. A. 116, 21213–21218. doi: 10.1073/pnas.1902376116
Wen, J., Thibeau-Sutre, E., Diaz-Melo, M., Samper-González, J., Routier, A., Bottani, S., et al. (2020). Convolutional neural networks for classification of Alzheimer’s disease: Overview and reproducible evaluation. Med. Image Anal. 63:101694. doi: 10.1016/j.media.2020.101694
Whittle, S., Allen, N. B., Fornito, A., Lubman, D. I., Simmons, J. G., Pantelis, C., et al. (2009). Variations in cortical folding patterns are related to individual differences in temperament. Psychiat. Res. 172, 68–74. doi: 10.1016/j.pscychresns.2008.06.005
Wu, Y., Besson, P., Azcona, E. A., Bandt, S. K., Parrish, T. B., Breiter, H. C., et al. (2020). Novel age-dependent cortico-subcortical morphologic interactions predict fluid intelligence: A multi-cohort geometric deep learning study. BioRxiv [preprint]. 2020.2010.2014.331199. doi: 10.1101/2020.10.14.331199
Xifra-Porxas, A., Ghosh, A., Mitsis, G. D., and Boudrias, M. H. (2021). Estimating brain age from structural MRI and MEG data: Insights from dimensionality reduction techniques. Neuroimage 231:117822. doi: 10.1016/j.neuroimage.2021.117822
Zuo, X. N., Anderson, J. S., Bellec, P., Birn, R. M., Biswal, B. B., Blautzik, J., et al. (2014). An open science resource for establishing reliability and reproducibility in functional connectomics. Sci. Data 1:140049. doi: 10.1038/sdata.2014.49
Keywords: geometric deep learning, brain shape, brain mapping, brain age, human aging, dementia, Alzheimer’s disease
Citation: Besson P, Rogalski E, Gill NP, Zhang H, Martersteck A and Bandt SK (2022) Geometric deep learning reveals a structuro-temporal understanding of healthy and pathologic brain aging. Front. Aging Neurosci. 14:895535. doi: 10.3389/fnagi.2022.895535
Received: 14 March 2022; Accepted: 27 July 2022;
Published: 23 August 2022.
Edited by:Jie Lu, Capital Medical University, China
Reviewed by:Diego Castillo-Barnes, University of Granada, Spain
Iman Beheshti, University of Manitoba, Canada
Copyright © 2022 Besson, Rogalski, Gill, Zhang, Martersteck and Bandt. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: S. Kathleen Bandt, firstname.lastname@example.org
†These authors have contributed equally to this work and share last authorship